BillionToOne, Inc. (BLLN) P/E Ratio History
Deep ValueTrading at 106.1x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2025–2026
Loading P/E history...
P/E Ratio Analysis
As of November 18, 2026, BillionToOne, Inc. (BLLN) trades at a price-to-earnings ratio of 106.1x, with a stock price of $97.50 and trailing twelve-month earnings per share of $0.92.
The current P/E is 85% below its 5-year average of 698.2x. Over the past five years, BLLN's P/E has ranged from a low of 117.4x to a high of 2311.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 25.0x, BLLN trades at a 324% premium to its sector peers. The sector includes 249 companies with P/E ratios ranging from 0.0x to 184.2x.
Relative to the broader market, BLLN commands a significant premium over the S&P 500 median P/E of 21.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BLLN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BLLN Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
BLLN P/E vs Peers
Reference and Genetic Labs peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $31B | 34.9 | 8.24 | +171%Best | |
| $3B | 32.7 | 4.89 | +14% | |
| $4B | 31.9 | - | -143% | |
| $255B | 36.0 | 17.04 | +7% | |
| $159B | 36.8 | - | -5% | |
| $49B | 33.8 | 2.30Best | +3% | |
| $10B | 9.4Lowest | - | +143% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
BLLN Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Sep 30 2026 | $106.44 | $0.91 | 117.4x | -83% |
| FY2026 Q2 | - | $119.98 | $0.62 | 193.5x | -72% |
| FY2026 Q1 | - | $78.94 | $0.46 | 169.9x | -76% |
| FY2025 Q4 | Dec 31 2025 | $81.84 | $0.04 | 2311.9x | +231% |
Average P/E for displayed period: 698.2x
BLLN Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
1+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BLLN — Frequently Asked Questions
Quick answers to the most common questions about buying BLLN stock.
What is BLLN's P/E ratio?
BillionToOne, Inc. (BLLN) trailing twelve-month P/E ratio is 106.1x, based on TTM diluted EPS of $0.92. The 5-year average P/E is 698.2x and the historical range spans 117.4x to 2311.9x.
Is BLLN stock overvalued or undervalued?
BLLN trades at 106.1x P/E, below its 5-year average of 698.2x. At the 0th percentile of its historical range (117.4x–2311.9x), the stock is priced at a discount to its own history.
Is BLLN stock expensive?
No, BLLN is not expensive on a historical basis. The current P/E of 106.1x is below the 5-year average of 698.2x and sits at the 0th percentile of its valuation range.
What is BLLN's historical P/E range?
Over the past 5 years, BLLN's P/E ratio has ranged from 117.4x to 2311.9x, with a median of 193.5x and an average of 698.2x. The current P/E of 106.1x places the stock at the 0th percentile of this range. Full historical data spans 2025–2026.
How does BLLN's P/E compare to the S&P 500?
BLLN trades at 106.1x P/E versus the S&P 500 median of 21.5x. The 393% premium to the market typically reflects higher expected earnings growth or quality.
How does BLLN's valuation compare to Healthcare peers?
BillionToOne, Inc. P/E of 106.1x compares to the Healthcare sector median of 25.0x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is BLLN's PEG ratio?
BLLN PEG ratio is N/A, based on a P/E of 106.1x and EPS growth of 103.4%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is BLLN's earnings yield?
BLLN earnings yield is 0.94%, the inverse of its 106.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.